苦柯胺B调控NLRP3/Caspase-1/GSDMD焦亡通路减轻脂多糖诱导的巨噬细胞炎症

Kukoamine B regulates pyroptosis mediated by NLRP3/Caspase-1/GSDMD pathway to alleviate lipopolysaccharide-induced macrophage inflammation

  • 摘要: 目的:探讨苦柯胺B(KB)对脂多糖(LPS)诱导的人单核细胞白血病THP-1细胞核苷酸结合寡聚化结构域样受体蛋白3(NLRP3)/半胱氨酸蛋白酶-1(Caspase-1)/消皮素D(GSDMD)焦亡通路的调控作用。方法:THP-1细胞经 100 ng/mL佛波酯(PMA)诱导24 h成为巨噬细胞,采用CCK-8法检测KB对细胞活力的影响,确定合适的浓度用于后续实验;由LPS联合三磷酸腺苷(ATP)诱导建立巨噬细胞炎症损伤模型(LPS组),采用不同浓度KB及NLRP3炎症小体抑制剂MCC950处理细胞,通过实时荧光定量PCR(RT-qPCR)法检测各组NLRP3Caspase-1、凋亡相关斑点样蛋白(ASC)、白细胞介素(IL)-GSDMD及高迁移率族蛋白B1(HMGB-1)mRNA表达,采用western blotting法检测炎症小体组分及焦亡相关蛋白的表达,酶联免疫吸附试验(ELISA)测定细胞上清液IL-1β的含量,检测细胞上清液乳酸脱氢酶(LDH)释放量,Annexin-V-PE/7-AAD染色检测细胞凋亡。结果:KB浓度为12.5~400 μmol/L范围内对THP-1细胞活力无明显影响。与对照组(未处理细胞)比较,LPS组NLRP3Caspase-1IL-1βGSDMDHMGB-1 mRNA表达上调,经MCC950或KB处理后,上述mRNA表达水平较LPS组下降(均P<0.05)。与对照组比较,LPS组NLRP3、Caspase-1、Cleaved Caspase-1、GSDMD、GSDMD-NT、HMGB1蛋白表达量均较对照组升高,经MCC950或KB处理后上述蛋白表达下调,细胞培养上清液中IL-1β分泌量和LDH释放量降低(均P<0.05),细胞凋亡减少。结论:KB可通过抑制NLRP3/Caspase-1/GSDMD通路介导的焦亡来改善LPS诱导的THP-1细胞炎症。

     

    Abstract: Objective: To investigate the regulatory effect of kukoamine B (KB) on the nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3)/Caspase-1/gasdermin D (GSDMD) pyroptosis pathway in human monocytic leukemia THP-1 cells induced by lipopolysaccharide (LPS). Methods: THP-1 cells were induced into macrophage by 100 ng/mL phorbol 12-myristate 13-acetate (PMA) for 24 h. The cell counting kit-8 (CCK-8) assay was used to assess the effect of KB on cell viability, and the appropriate concentrations were determined for subsequent experiments. The inflammation injury model of macrophage (LPS group) was established by LPS combined with adenosine triphosphate (ATP). The cells were treated with different concentrations of KB and NLRP3 inflammasome inhibitor MCC950. Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was employed to detect the mRNA expression of NLRP3, Caspase-1, apoptosis-related spot-like protein (ASC), interleukin (IL)-1β, GSDMD and high mobility group protein B-1 (HMGB-1) in each group. Western blotting was used to detect the expression of the inflammasome components and pyroptosis-associated proteins. The IL-1β level in supernatant was determined via enzyme-linked immunosorbent assay (ELISA), the release of lactate dehydrogenase (LDH) in the cell supernatant was assessed, and the Annexin-V-PE/7-aminoactinomycin (7-AAD) staining was utilized to detect apoptosis. Results: The concentrations of KB ranging from 12.5 μmol/L to 400 μmol/L had no significant effect on the viability of THP-1 cells. In comparison to the control group (untreated cells), the expression of NLRP3, Caspase-1, IL-1β, GSDMD and HMGB-1 mRNA was up-regulated in the LPS group. After MCC950 or KB treatment, the above changes were significantly reversed (P<0.05). The protein expression of NLRP3, Caspase-1, Cleaved caspase-1, GSDMD, GSDMD-NT, and HMGB1 in the LPS group were higher than those in the control group, and the above protein expression was down-regulated after MCC950 or KB treatment. The secretion of IL-1β and LDH release in cell culture supernatant were decreased (both P<0.05), and the apoptosis was reduced. Conclusion: KB can alleviate LPS-induced inflammation in THP-1 cells by inhibiting pyroptosis mediated by the NLRP3/Caspase-1/GSDMD pathway.

     

/

返回文章
返回